Amphastar Pharmaceuticals Profit Margin 2012-2024 | AMPH
Current and historical gross margin, operating margin and net profit margin for Amphastar Pharmaceuticals (AMPH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Amphastar Pharmaceuticals net profit margin as of September 30, 2024 is 21.8%.
| Amphastar Pharmaceuticals Annual Profit Margins |
| Amphastar Pharmaceuticals Quarterly Profit Margins |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.097B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
